Gene Solutions Overview

  • Founded
  • 2006
  • Status
  • Private
  • Employees
  • 8
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $2.37M
Latest Deal Amount
  • Investors
  • 2

Gene Solutions General Information


Developer of mitochondrial therapeutics designed to enhance drug pipelines in the field of central nervous system diseases. The company's therapeutics are used in the treatment of neural and muscular degenerative diseases, enabling healthcare providers to treat diseases such as Alzheimer's, Parkinson's and Schizophrenia.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • One Boarshead Pointe
  • Suite 109
  • Charlottesville, VA 22903
  • United States
+1 (781) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Gene Solutions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A) 03-Mar-2021 $2.37M 00.000 Completed Generating Revenue
4. Later Stage VC 02-Oct-2015 00000 00.000 Completed Generating Revenue
3. Seed Round 25-Feb-2013 00000 00000 Completed Generating Revenue
2. Grant 01-Jan-2010 $22.5K $350K Completed Generating Revenue
1. Angel (individual) 26-Aug-2008 $350K $350K Completed Startup
To view Gene Solutions’s complete valuation and funding history, request access »

Gene Solutions Executive Team (5)

Name Title Board Seat Contact Info
William Parker MD Co-Founder, President & Board Member
Edward Connell Co-Founder, Chief Financial Officer & Board Member
Susan Jones Ph.D Business Development & Board Member
Brian Warrington Ph.D Head of Chemistry Lead Discovery & Board Member
David Patteson Co-Founder, Chairman & Executive Officer
To view Gene Solutions’s complete executive team members history, request access »

Gene Solutions Board Members (7)

Name Representing Role Since
Brian Warrington Ph.D Gene Solutions Head of Chemistry Lead Discovery & Board Member 000 0000
David Patteson Self Co-Founder, Chairman & Executive Officer 000 0000
Edward Connell Gene Solutions Co-Founder, Chief Financial Officer & Board Member 000 0000
James Oury Gene Solutions Board Member 000 0000
James Powers Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Gene Solutions Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gene Solutions Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
PIPV Capital PE/Buyout Minority 000 0000 000000 0
The University of Virginia Corporation 000 0000 000000 0
To view Gene Solutions’s complete investors history, request access »